Precision Molecular Pathology of Liver Cancer
Published on 25. January 2018
Book
Hardback
XI, 271 pages
978-3-319-68080-4 (ISBN)
Description
Provides the most updated knowledge on hepatocellular carcinomaFeatures instructive illustrations and tablesWritten by experts in the field
More details
Series
Edition
2018 ed.
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
8 s/w Abbildungen, 22 farbige Abbildungen
XI, 271 p. 30 illus., 22 illus. in color.
Dimensions
Height: 241 mm
Width: 160 mm
Thickness: 20 mm
Weight
646 gr
ISBN-13
978-3-319-68080-4 (9783319680804)
DOI
10.1007/978-3-319-68082-8
Schweitzer Classification
Other editions
Additional editions
Book
06/2019
Springer
€96.29
Shipment within 10-15 days
E-Book
01/2018
1st Edition
Springer
€96.29
Available for download
Person
Chen Liu, MDUniversity of FloridaFL, USA
Content
Overview: Current diagnosis and treatment of HCC in the era of precision medicine.- The etiology and pathogenesis of hepatocellular carcinoma.- Histological classification of HCC and its clinical implication.- Molecular classification of HCC and precision medicine.- Recent advances in HCC genomics, next generation sequencing, and bioinformatics.- Epigenetic regulations in the pathogenesis of HCC and the clinical application.- Biomarker discovery and validation in HCC diagnosis, prognosis, and therapy.- HCC cancer stem cell signaling pathway.- Epithelial and mesenchymal transition (EMT) and its biological significance in HCC.- HCC metastasis and circulating tumor cells.- Biological role and potential clinical application of miRNA in hepatocellular carcinoma.- Immune regulation in HCC and the prospect of immunotherapy.- Liver cell dysplasia and the development of HCC.- Molecular pathogenesis of hepatic adenoma and its malignant transformation.- The role of liver biopsy in HCC early diagnosis and treatment decision.- The future prospect on surgical approaches for HCC.- The future prospect on targeted therapy for HCC.